BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


SEARCH JOBS








 Company News
Rexahn Pharmaceuticals, Inc. to Present Data on the Mechanism of Action of RX-5902: a First-in-Class Inhibitor of p68 Helicase for the Treatment of Solid Tumors at American Association for Cancer Research Annual Meeting 2013 4/2/2013 9:54:31 AM    More...
Rexahn Pharmaceuticals, Inc. to Present at the 25th Annual ROTH Conference 3/11/2013 6:15:29 AM    More...
Rexahn Pharmaceuticals, Inc. Provides Key Goals for 2013 2/19/2013 9:34:30 AM    More...
Rexahn Pharmaceuticals, Inc. Appoints Peter D. Suzdak as CEO 1/22/2013 7:38:34 AM    More...
Rexahn Pharmaceuticals, Inc. Expands its Intellectual Property Around Class of Potent Anti-cancer Isoquinolinamine Compounds 12/17/2012 9:49:59 AM    More...
Rexahn Pharmaceuticals, Inc. Closes Public Offering for $6,600,000 in Gross Proceeds 12/5/2012 10:50:08 AM    More...
Rexahn Pharmaceuticals, Inc. Prices Public Offering of Stock 11/29/2012 9:31:56 AM    More...
Rexahn Pharmaceuticals, Inc. Issued U.S. Patent for Quinoxalinyl-piperazine Compounds 11/21/2012 10:50:55 AM    More...
Rexahn Pharmaceuticals, Inc. Granted European Patent for Novel Anti-cancer Isoquinolinamine Compounds 9/26/2012 9:31:09 AM    More...
Rexahn Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 14th Annual Healthcare Conference 9/6/2012 10:15:15 AM    More...
12345678910...